Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fromm

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Molecular Cancer Therapeutics|August 11, 2021
Evaluation of Preclinical Activity of Isatuximab in Patients with Acute Lymphoblastic LeukemiaAnlai Wang, Zhili Song, Gang Zheng, et al.
Blood Advances|July 22, 2020
Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemiaRyan D Cassaday, Kelsey-Leigh A Garcia, Jonathan R Fromm, et al.
Cytometry. Part B, Clinical Cytometry|October 22, 2025
A practical approach to panel design, validation, and interpretation for the evaluation of T-cell neoplasms by flow cytometryJean Oak, Felipe Magalhaes Furtado, Katherine A Devitt, et al.
Science Translational Medicine|May 18, 2012
High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemiaDavid Wu, Anna Sherwood, Jonathan R Fromm, et al.
Growth Factors (Chur, Switzerland)|January 1, 1997
Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptorA M Dougher, H Wasserstrom, L Torley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 27, 2018
Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance TherapyAndrew J Cowan, Philip A Stevenson, Edward N Libby, et al.
Head & Neck|November 22, 2022
Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostatCassie Pan, Qian Vicky Wu, Jenna Voutsinas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 11, 2026
Biomarkers Informed by Single-Cell and Spatial Transcriptomics - Biomarkers for Grade 3 Follicular LymphomaAarti Kanzaria, Sonali Arora, Anisha Naik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland CancerCristina P Rodriguez, Qian Vicky Wu, Jenna Voutsinas, et al.
Cancer Medicine|February 22, 2023
Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitorsCassie Pan, Qian Vicky Wu, Jenna Voutsinas, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Molecular Cancer Therapeutics|August 11, 2021
Evaluation of Preclinical Activity of Isatuximab in Patients with Acute Lymphoblastic LeukemiaAnlai Wang, Zhili Song, Gang Zheng, et al.
Blood Advances|July 22, 2020
Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemiaRyan D Cassaday, Kelsey-Leigh A Garcia, Jonathan R Fromm, et al.
Cytometry. Part B, Clinical Cytometry|October 22, 2025
A practical approach to panel design, validation, and interpretation for the evaluation of T-cell neoplasms by flow cytometryJean Oak, Felipe Magalhaes Furtado, Katherine A Devitt, et al.
Science Translational Medicine|May 18, 2012
High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemiaDavid Wu, Anna Sherwood, Jonathan R Fromm, et al.
Growth Factors (Chur, Switzerland)|January 1, 1997
Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptorA M Dougher, H Wasserstrom, L Torley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 27, 2018
Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance TherapyAndrew J Cowan, Philip A Stevenson, Edward N Libby, et al.
Head & Neck|November 22, 2022
Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostatCassie Pan, Qian Vicky Wu, Jenna Voutsinas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 11, 2026
Biomarkers Informed by Single-Cell and Spatial Transcriptomics - Biomarkers for Grade 3 Follicular LymphomaAarti Kanzaria, Sonali Arora, Anisha Naik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland CancerCristina P Rodriguez, Qian Vicky Wu, Jenna Voutsinas, et al.
Cancer Medicine|February 22, 2023
Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitorsCassie Pan, Qian Vicky Wu, Jenna Voutsinas, et al.
Pageof 11